Editors’ Picks, October 2026: Surgical De-escalation, New CAR T-cell Approaches, and More
The October 2026 Editors’ Picks from AACR journals include findings on multiple primary cancers in World Trade Center responders,...
Tag: CAR T-cell therapy
The October 2026 Editors’ Picks from AACR journals include findings on multiple primary cancers in World Trade Center responders,...
Featuring insights from Carl H. June, MD, FAACR, this post covers the ongoing challenges facing CAR T-cell therapy and...
With seven CAR T-cell therapies approved by the U.S. Food and Drug Administration, this innovative immunotherapy has revolutionized the...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Researchers are working on multiple innovative approaches to cancer vaccines, including nanoparticle delivery, a universal booster, and more.
New clinical trials are exploring an array of CAR T-cell approaches for children with cancers of the brain and...
The summer, espionage-themed edition of From the Bench highlights in vivo cancer therapies that spring into action inside the...
A study suggests that modifying a patient’s gut microbiome could make their cancer more likely to respond to CAR...
For April 2025, the editors of AACR's 10 journals highlighted studies on evolution in glioblastoma, new cancer treatment approaches,...
A promising new personalized vaccine headlines several recent breakthroughs that highlight progress in kidney cancer research.